Connect with us

Hi, what are you looking for?

News

Adobe, Smith & Wesson, BlackBerry, Orphazyme: What to Watch When the Stock Market Opens Today

Adobe, Smith & Wesson, BlackBerry, Orphazyme: What to Watch When the Stock Market Opens Today

U.S. stock futures ticked lower, putting the Dow on track for its worst weekly performance since the end of January. Here’s what we’re watching ahead of Friday’s trading action.

  • Futures tied to the Dow Jones Industrial Average slipped 0.4% The index of blue-chip stocks had dropped 1.9% this week through Thursday.
  • S&P 500 futures were down 0.3%, putting the benchmark index on track to end a three-week streak of gains. Nasdaq-100 futures edged down 0.1%, pointing to modest losses in large technology stocks at the opening bell. Read our full market wrap.
What’s Coming Up
  • The U.S. Juneteenth federal holiday is observed for the first time. The actual holiday falls on June 19, a Saturday this year. Markets will be open as usual, at least this time around.
  • The Baker Hughes rig count, a proxy for drilling activity, is out at 1 p.m. ET.
Market Movers to Watch
  • With guns a-blazing:

    Smith & Wesson

    SWBI -3.07%

    shares were among the premarket risers, adding 5.3% after the firearms maker said its sales surged in the latest quarter amid strong demand.

Smith & Wesson Brands launched its first dividend.



Photo:

Bing Guan/Bloomberg News

  • Adobe

    ADBE 1.48%

    shares climbed 2.9% premarket after the software maker’s quarterly profit and forward guidance came in ahead of expectations.

  • Trading was mostly quiet among the meme stocks, but a few were managing to post mild gains.

    BlackBerry

    BB 4.89%

    was up 2.1% premarket and

    Clover Health

    CLOV -3.01%

    added 1.3%.

  • Orphazyme

    ORPH -10.18%

    is on the move again, and this time there’s a catalyst—unlike the recent volatility that the company said it could not explain. The FDA rejected the biopharmaceutical company’s application for approval of a treatment for a rare progressive genetic disorder, and it’s U.S.-traded shares plunged 53% ahead of the bell.

  • Drug company

    Geron

    was flying in the opposite direction, up 22% ahead of the bell. Late Thursday it released data from a phase 2 study of a treatment of myelofibrosis.

Market Facts
  • Gold futures declined 4.5% on Thursday, the largest drop in over 10 months. That took gold down to $1,777.80 a troy ounce, its lowest since early May. Friday morning they edged up 0.6%.
  • A record $756 billion flowed into the Federal Reserve’s reverse repo facility on Thursday, a day after the central bank boosted the return on a key part of its interest rate control tool kit.
Chart of the Day
  • Nonprofessional investors are continuing to upend financial markets and build on their forceful entrance into the trading arena last year.
Must Reads Since You Went to Bed

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

You May Also Like

World

France, which has opened its borders to Canadian tourists, is eager to see Canada reopen to the French. The Canadian border remains closed...

Health

Kashechewan First Nation in northern Ontario is experiencing a “deepening state of emergency” as a result of surging COVID-19 cases in the community...

World

The virus that causes COVID-19 could have started spreading in China as early as October 2019, two months before the first case was identified in the central city of Wuhan, a new study...

World

April Ross and Alix Klineman won the first Olympic gold medal for the United States in women’s beach volleyball since 2012 on Friday,...